Pulmatrix Inc

NASDAQ:PULM

2.69

-0.07 (-2.43%)

7:46:00 PM EDT: $2.68 -0.01 (-0.37%)

Market Cap (Intraday)	9.82M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$1.51 Million
Adjusted EPS	-$1.23

See more estimates

10-Day MA	$2.76
50-Day MA	$2.84
200-Day MA	$3.51

See more pivots

Pulmatrix Inc Stock, NASDAQ:PULM

99 Hayden Avenue, Suite 390, Lexington, Massachusetts 02421

United States of America

Phone: +1.781.357.2333

Number of Employees: 29

http://www.pulmatrix.com

Description

Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the development and discovery of novel inhaled therapeutics products. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov, and Robert S. Langer, Jr. on June 15, 2015 and is headquartered in Lexington, MA.